InvestorsHub Logo
Followers 4
Posts 2010
Boards Moderated 0
Alias Born 09/19/2008

Re: CYRXorbust post# 10246

Wednesday, 06/15/2016 3:39:05 PM

Wednesday, June 15, 2016 3:39:05 PM

Post# of 12137
I think strategically, specifically after today's release, the company has the bases covered.. To this degree, management has done a good job.. The question, what is CryoPort's strength.. Most likely Cellular therapies. And that is most likely where we as shareholders will start to see cryogenic packaging demand pick up, and bio storage as well... But long before the process starts to roll out, preparation is warranted. Consulting, stable, probably not a direct revenue driver, but indirectly, most likely helps our company and partners.. Don't know much about moving labs, but possibly good and bad months.. Bio storage is important, but I gather will be very important when immunotherapies take hold.. I recently read an article about Marken.. In the article, Marken is preparing for the major demand expected from personalized medicine, which should be soon...I gather all our partners are as well..
The big difference, our partners have money to wait it out and invest..
We're in the right field, we have the right solution(s)..
Prior management were scum, I think they're a few issues with current management, but I think current management has set the company in the direction, operationally.. If the company can raise money intelligently,
Then time should be on their side to see this through...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News